Clinical Diagnostics Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Clinical Diagnostics Market: By Test (Lipid Panel, Metabolic Panel, Liver Panel, Renal Panel, Complete Blood Count, Electrolyte Testing, Infectious Disease Testing, and Other Tests), By Product (Instruments, Reagents, and Data Management Systems), By End User (Hospital, Diagnostic Laboratory, Point-of-Care Testing, and Other End Users) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

Clinical Diagnostics Market size was valued at USD 50.11 billion in 2021, growing at a significant CAGR of 5.02% over 2022-2028. Some of the key factors influencing the market growth include growing in patients with long term diseases/ disorders like diabetes, cardiovascular diseases, hypertension etc. where frequent testing required. Also increase in geriatric population plays a key role in the market. Expansion and advancements of these diagnostic testing’s are also thriving the market growth. Increase in health expenditure, rising in awareness about health care and testing in people are the important factors of the market growth. However, high requirement of initial capital amount, stringent regulations by the government, complex operating procedure of equipment, lack of skilled professionals are somehow restraining the market in some regions.  Clinical diagnostics is the process of identifying a disease by signs, symptoms, a patient’s medical history, and a physical examination. They include the production, development, and marketing of test kits, automated test systems, and informatics systems. They aid in disease management to enhance patients’ overall health and well-being. They also assist in the classification of patients with various diseases so that focused medication can be given to them. Additionally, they can enhance the effectiveness of medicines, forecast therapeutic efficacy, and protect patients from long-term problems. As a result, clinical diagnostics are widely used in point-of-care testing, diagnostic laboratories, and hospital laboratories all over the world.

Clinical Diagnostics Market

MARKET SUMMARY
-
5.02% CAGR
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 5.02%
  • Largest Market– North America
  • Fastest Growing Market– Asia Pacific

Clinical Diagnostics Market

  • The report gives a comprehensive outlook on clinical diagnostics across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.
  • The report on global clinical diagnostics market gives historical, current, and future market sizes (US$ Mn) on the basis of test, product, end user, and region.
Key Players
  • Abbott Laboratories
  • ARUP Laboratories
  • Becton
  • Bioscientia Healthcare
  • Bio-Rad Laboratories Inc.
Clinical Diagnostics Market

The development of complex and specialised tests for early illness diagnosis and disease management, as well as rising demand for lab automation, are expected to fuel expansion in the worldwide clinical diagnostics market throughout the forecast period. The growing use of point-of-care diagnostics has ushered in a trend of decentralisation in the healthcare business.


Asia Pacific got significant share

Clinical Diagnostics Market

Asia Pacific accounted for larger revenue share in global clinical diagnostics market with considerable CAGR. The growth in this region can be attributed to increase in geriatric population, rise in diseased patients, more advanced diagnostic techniques like PACS (picture archiving and communication systems) and EMR (electronic medical records)etc., high amount of disposable income for diagnosing tests placed this region top in the global market

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Clinical Diagnostics Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content


Report

Company Profile

  • Abbott Laboratories
  • ARUP Laboratories
  • Becton
  • Bioscientia Healthcare
  • Bio-Rad Laboratories Inc.
  • Bio-Reference Laboratories
  • BioMérieux
  • Charles River Laboratories
  • Clarient Inc.
  • Danaher Corporation, Becton
  • Dickinson and Company
  • Diasorin
  • Genoptix Medical Laboratory
  • Genzyme Corporation
  • Healthscope Limited.
  • Hologic Inc
  • Labco S.A.
  • Laboratory Corporation of America Holdings (Labcorp)
  • Ortho Clinical Diagnostics
  • Qiagen
  • Quest Diagnostics Inc.
  • Roche Diagnostics
  • Siemens AG Healthcare
  • Sonic Healthcare Ltd
  • Thermo Fisher Scientific

Description

Clinical Diagnostics Market size was valued at USD 50.11 billion in 2021, growing at a significant CAGR of 5.02% over 2022-2028. Some of the key factors influencing the market growth include growing in patients with long term diseases/ disorders like diabetes, cardiovascular diseases, hypertension etc. where frequent testing required. Also increase in geriatric population plays a key role in the market. Expansion and advancements of these diagnostic testing’s are also thriving the market growth. Increase in health expenditure, rising in awareness about health care and testing in people are the important factors of the market growth. However, high requirement of initial capital amount, stringent regulations by the government, complex operating procedure of equipment, lack of skilled professionals are somehow restraining the market in some regions.  Clinical diagnostics is the process of identifying a disease by signs, symptoms, a patient’s medical history, and a physical examination. They include the production, development, and marketing of test kits, automated test systems, and informatics systems. They aid in disease management to enhance patients’ overall health and well-being. They also assist in the classification of patients with various diseases so that focused medication can be given to them. Additionally, they can enhance the effectiveness of medicines, forecast therapeutic efficacy, and protect patients from long-term problems. As a result, clinical diagnostics are widely used in point-of-care testing, diagnostic laboratories, and hospital laboratories all over the world.

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX